Evidence map›Paper›PMID 37561245›Full record

ArticleJournal of community health2024

Gaps in HIV and Hepatitis C Testing Among 3486 HIV-Negative Men Who have Sex with Men in Spain in the Era of Highly Effective Antiviral Therapies.

Julieta Politi, Marta Donat, Juan Miguel Guerras, Oskar Ayerdi, David Palma, Jorge Néstor García, Gregorio Barrio, María José Belza, Methysos Project Group

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of community health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Julieta PolitiEscuela Nacional de Sanidad, Instituto de Salud Carlos III, Av. Monforte de Lemos, 5, 28029, Madrid, Spain.
Marta DonatCIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Juan Miguel GuerrasEscuela Nacional de Sanidad, Instituto de Salud Carlos III, Av. Monforte de Lemos, 5, 28029, Madrid, Spain. gerrasmoreira@hotmail.com.ORCID 0000-0001-6708-3291
Oskar AyerdiCentro Sanitario Sandoval, Instituto de Investigación Sanitaria San Carlos, Hospital Clínico San Carlos, Madrid, Spain.
David PalmaCIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Jorge Néstor GarcíaUnidad de ITS de Vall d'Hebron-Drassanes, Hospital Vall d'Hebron, Barcelona, Spain.
Gregorio Barrio *Escuela Nacional de Sanidad, Instituto de Salud Carlos III, Av. Monforte de Lemos, 5, 28029, Madrid, Spain.
María José Belza *Escuela Nacional de Sanidad, Instituto de Salud Carlos III, Av. Monforte de Lemos, 5, 28029, Madrid, Spain.
Methysos Project Group
Instituto de Salud Carlos III · ESVall d'Hebron Hospital Universitari · ESAgència de Salut Pública de Catalunya · ESCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESInstituto de Investigación Sanitaria del Hospital Clínico San Carlos · ES

Funding

Instituto de Salud Carlos III CM20CIII/00001Instituto de Salud Carlos III PI17CIII/00037Instituto de Salud Carlos III PI18CIII/00047
6 · The paper itself

Abstract

High uptake of HIV and hepatitis C (HCV) testing in Gay, bisexual, and other men who have sex with men (GBMSM) is needed to interrupt transmission. The objective was to identify subgroups with increased probability of lack of testing among HIV-negative GBMSM in Spain. Cross-sectional study including 3486 HIV-negative GBMSM attending prevention facilities in Madrid and Barcelona, 2018-2020. Data came from self-administered online sociodemographic, health, and risk behaviors questionnaires. Outcomes were lack of HCV (lifetime) and HIV (lifetime, last year) testing. Crude and adjusted prevalences and prevalence ratios were assessed for each outcome using negative binomial regression models. Lifetime lack of HIV and HCV testing prevalence was 6.3% and 35.8%, respectively, while lack of HIV testing in the last year was 22.4%. Prevalences were also substantial in GBMSM with high-risk behaviors. After sociodemographic adjustment, the highest probability of lack of HCV testing (lifetime) and HIV (last year) was among GBMSM with insufficient viral hepatitis knowledge, no history of STI, or HCV (or HIV) testing, aged < 25, non-outness about sex life with men, and less high-risk behaviors. Lack of HCV (lifetime) and HIV testing (last year) among HIV-negative GBMSM in Spain is still high, despite high-risk behaviors.

Indexed as

Hepatitis CHIV InfectionsSexual and Gender MinoritiesAntiviral AgentsCross-Sectional StudiesHepacivirusHomosexuality, MaleHumansMaleSpainAntiviral AgentsCross-sectional studyEpidemiologyHepatitis CHIVMen who have sex with menTesting

Identifiers

PMID37561245
OpenAlexW4385717029

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.